Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Withdrawn before enrolling

Conditions studied: Glioma, Meningioma

In brief

Objectives: This study is looking at the level of vascular endothelial growth factor (VEGF) circulating in the blood stream of patients diagnosed with either a meningioma or a glioma. The questions that will be addressed include: 1. Can VEGF level alert us to tumor progression or recurrence before MRI changes occur? 2. Is the VEGF level an indicator of the response to treatment? 3. Does the VEGF level correlate with tumor histology and behavior? 4. Is there a relationship between VEGF level and outcome?

Key facts

Study ID

NCT00985036

Run by

Marquette General Health System

People needed

0

Starts

2009-09-01

Expected to finish

2012-01-01

Last updated by the study team

2012-04-24

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• any patient presenting with glioma or meningioma

You may not qualify if…

• a different type of brain tumor

Where it is running

• Marquette General Hospital — Marquette, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.